Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+10.0%
5Y CAGR+55.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+10.0%/yr
Annual compound
5Y CAGR
+55.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
9.1x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.38M | +3.4% |
| 2024 | $35.17M | +9.8% |
| 2023 | $32.04M | +17.3% |
| 2022 | $27.32M | +73.7% |
| 2021 | $15.73M | +292.7% |
| 2020 | $4.00M | +521.9% |
| 2019 | $644000.00 | - |